All Stories

  1. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed

    Article • Scientific Reports, September 2017, Springer Science + Business Media

    Dr Matthew F Wipperman

  2. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy

    Article • Microbiome, July 2017, Springer Science + Business Media

    Dr Matthew F Wipperman

  3. Unraveling Cholesterol Catabolism in Mycobacterium tuberculosis: ChsE4-ChsE5 α2β2 Acyl-CoA Dehydrogenase Initiates β-Oxidation of 3-Oxo-cholest-4-en-26-oyl CoA

    Article • ACS Infectious Diseases, January 2015, American Chemical Society (ACS)

    Dr Matthew F Wipperman

  4. How Mycobacterium tuberculosis uses cholesterol

    Article • Critical Reviews in Biochemistry and Molecular Biology, March 2014, Taylor & Francis

    Dr Matthew F Wipperman

  5. Shrinking the FadE Proteome of Mycobacterium tuberculosis: Insights into Cholesterol Metabolism through Identification of an  2 2 Heterotetrameric Acyl Coenzyme A Dehydrogenase Family

    Article • Journal of Bacteriology, July 2013, ASM Journals

    nicole sampson, Dr Matthew F Wipperman

  6. Experimental evidence of a cyclopropylcarbinyl conjugative electronic effect

    Article • Organic & Biomolecular Chemistry, January 2013, Royal Society of Chemistry

    Dr Matthew F Wipperman

  7. Thermal Isomerizations of cis,anti,cis-Tricyclo[7.4.0.02,8]tridec-10-ene

    Article • The Journal of Organic Chemistry, March 2012, American Chemical Society (ACS)

    Dr Matthew F Wipperman